Answered step by step
Verified Expert Solution
Question
1 Approved Answer
Company 1 Balance Sheet ASSETS December 31, 2022 December 31, 2021 December 31, 2020 Current assets: Cash and cash equivalents 858 2364 2446 Accounts receivable
Company 1 Balance Sheet
ASSETS | December 31, 2022 | December 31, 2021 | December 31, 2020 |
Current assets: | |||
Cash and cash equivalents | 858 | 2364 | 2446 |
Accounts receivable | 2943 | 2770 | 2690 |
Inventories of supplies, at cost | 405 | 384 | 368 |
Assets held for sale | 140 | ||
Other current assets | 1775 | 1557 | 1503 |
Total current assets | 5981 | 7075 | 7147 |
Investments and other assets | 3147 | 3254 | 2534 |
Deferred income taxes | 19 | 65 | 325 |
Property and equipment, at cost, less accumulated depreciation and amortization | 6462 | 6427 | 6692 |
($6,201 at December 31, 2022, $5,960 at December 31, 2021, and $6,043 at December 31, 2020) | |||
Goodwill | 10123 | 9261 | 8808 |
Other intangible assets, at cost, less accumulated amortization | 1424 | 1497 | 1600 |
($1,428 at December 31, 2022, $1,374 at December 31, 2021, and $1,284 at December 31, 2020) | 0.5745591382 | ||
Total assets | 27156 | 27579 | 27106 |
LIABILITIES AND EQUITY | |||
Current liabilities: | |||
Current portion of long-term debt | 145 | 135 | 145 |
Accounts payable | 1504 | 1330 | 1207 |
Accrued compensation and benefits | 778 | 896 | 942 |
Professional and general liability reserves | 255 | 254 | 243 |
Accrued interest payable | 213 | 203 | 248 |
Liabilities held for sale | -- | -- | 70 |
Contract liabilities | 110 | 959 | 659 |
Other current liabilities | 1471 | 1362 | 1333 |
Total current liabilities | 4476 | 5109 | 4847 |
Long-term debt, net of current portion | 14934 | 15511 | 15574 |
Professional and general liability reserves | 790 | 791 | 735 |
Defined benefit plan obligations | 331 | 421 | 497 |
Deferred income taxes | 217 | 36 | 29 |
Contract liabilities long-term | 13 | 15 | 918 |
Other long-term liabilities | 1787 | 1439 | 1617 |
Total liabilities | 22548 | 23322 | 24217 |
Commitments and contingencies | |||
Redeemable noncontrolling interests in equity of consolidated subsidiaries | 2149 | 2203 | 1952 |
Equity: | |||
Shareholders equity: | |||
Common stock, $0.05 par value; authorized 262,500,000 shares; 156,462,456 shares issued at December 31, 2022 and 155,520,691 shares issued at December 31, 2021 | 8 | 8 | 7 |
Additional paid-in capital | 4778 | 4877 | 4844 |
Accumulated other comprehensive loss | -181 | -233 | -218 |
Accumulated deficit | -803 | -1214 | -2128 |
Common stock in treasury, at cost, 54,215,871 shares at December 31, 2022 and 48,331,649 shares at December 31, 2021 | -2660 | -2410 | -2414 |
Total shareholders equity | 1142 | 1028 | 28 |
Noncontrolling interests | 1317 | 1026 | 909 |
Total equity | 2459 | 2054 | 937 |
Total liabilities and equity | 27156 | 27579 | 27106 |
Company 1 Income Statement
2022 | 2021 | 2020 | |
Net operating revenues | 19174 | 19,485 | 17,640 |
Grant income | 194 | 191 | 882 |
Equity in earnings of unconsolidated affiliates | 216 | 218 | 169 |
Operating Expenses: | |||
Salaries, wages and benefits | 8844 | 8,878 | 8,418 |
Supplies | 3273 | 3,328 | 2,982 |
Other operating expenses, net | 3998 | 4,206 | 4,125 |
Depreciation and amortization | 841 | 855 | 857 |
Impairment and restructuring charges, and acquisition-related costs | 226 | 85 | 290 |
Litigation and investigation costs | 70 | 116 | 44 |
Net gains on sales, consolidation and deconsolidation of facilities | -1 | -445 | -14 |
Operating income | 2333 | 2,871 | 1,989 |
Interest expense | -890 | -923 | -1,003 |
Other non-operating income, net | 10 | 14 | 1 |
Loss from early extinguishment of debt | -109 | -74 | -316 |
Income from continuing operations, before income taxes | 1344 | 1,888 | 671 |
Income tax benefit (expense) | -344 | -411 | 97 |
Income from continuing operations, before discontinued operations | 1000 | 1,477 | 768 |
Discontinued operations: | |||
Income (loss) from operations | 1 | -1 | |
Income (loss) from discontinued operations | 1 | -1 | |
Net income | 1001 | 1,476 | 768 |
Less: Net income available to noncontrolling interests | 590 | 562 | 369 |
Net income available to Tenet Healthcare Corporation common shareholders | 411 | 914 | 399 |
Amounts available to Tenet Healthcare Corporation common shareholders | |||
Income from continuing operations, net of tax | 410 | 915 | 399 |
Income (loss) from discontinued operations, net of tax | 1 | -1 | |
Net income available to Tenet Healthcare Corporation common shareholders | 411 | 914 | 399 |
Earnings (loss) per share available (attributable) to Tenet Healthcare Corporation common shareholders: | |||
Basic | |||
Continuing operations | 3.83 | 8.56 | 3.8 |
Discontinued operations | 0.01 | -0.01 | |
3.84 | 8.55 | 3.8 | |
Diluted | |||
Continuing operations | 3.78 | 8.43 | 3.75 |
Discontinued operations | 0.01 | -0.01 | |
3.79 | 8.42 | 3.75 | |
Weighted average shares and dilutive securities outstanding (in thousands): | |||
Basic | 106929 | 106,833 | 105,010 |
Diluted | 110516 | 108,571 | 106,263 |
Company 1 | |||
2022 | 2021 | 2020 | |
Debt management | |||
Debt Ratio (Total debt-to-assets) | |||
Liabilities-to-assets ratio | |||
Times-interest-earned ratio | |||
EBITDA coverage ratio | |||
Profitability | |||
Profit Margin | |||
Basic Earning Power | |||
Return on Assets | |||
Return on Equity |
Step by Step Solution
There are 3 Steps involved in it
Step: 1
Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started